Statistics
Publications
35
Citations
3.5K
H-Index
28
Active since
1992
Lawrence B. Snyder is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.
Publications per year
1992–2024
35
35
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 937 citations · Full text
Total Synthesis of Baccatin III and Taxol
Samuel J. Danishefsky, John J. Masters, Wendy B. Young et al. · Journal of the American Chemical Society · 1996 · 433 citations
John J. Masters, J. T. Link, Lawrence B. Snyder et al. · Angewandte Chemie International Edition in English · 1995 · 214 citations
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
Taavi K. Neklesa, Lawrence B. Snyder, Ryan R. Willard et al. · Journal of Clinical Oncology · 2019 · 207 citations
Medicine, Oncology, Pharmacology +16
Identification of Hepatitis C Virus NS5A Inhibitors
Julie A. Lemm, Donald R. O’Boyle, Mengping Liu et al. · Journal of Virology · 2009 · 194 citations · Full text
1–5 of 35